tailorx: phase 3 trial validating a 21-gene expression assay in breast cancer
Published 8 years ago • 226 plays • Length 5:34Download video MP4
Download video MP3
Similar videos
-
5:32
tailorx: prospective phase 3 trial validating a 21-gene expression assay in breast cancer
-
5:54
roxane: impact of 21-gene assay on treatment for early breast cancer
-
0:38
rxponder: 21-gene assay informs chemotherapy benefit in hr node-positive breast cancer
-
5:19
tailorx: an update incl 12-year event rates in woman with er lymph node-negative breast cancer
-
1:13:21
clinical outcomes in early breast cancer with a high 21-gene recurrence score tailorx rct
-
0:55
the clinical impact of gene expression assays on early luminal breast cancer
-
3:57
overview of prospective phase 3 planb trial of 21-gene recurrence score® result in breast cancer
-
3:43
early stage breast cancer: tailorx trial
-
3:18
5-year outcomes from planb: phase 3 trial of 21-gene recurrence score® result in breast cancer
-
8:22
molecular profiling in early breast cancer
-
1:19
gene expression assays to identify patients with breast cancer for neoadjuvant treatment
-
4:39
results and impact of tailorx: trial assigning individualized options for treatment (rx)
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
2:45
trial updates in breast cancer from asco: tailorx, pakt, monarch 2 & monaleesa-3
-
2:46
ameera-3: amcenestrant does not improve pfs in er /her2- breast cancer
-
58:32
molecular testing in breast cancer: will it become standard practice?
-
2:36
providing predictive and prognostic biomarkers for breast cancer from the tailorx trial
-
0:40
assessing the role of 21-gene assays in breast cancer
-
1:58
validation of polar, a 16-gene molecular signature, for breast conserving surgery /- radiotherapy